Almost 15 years ago, doctors were treating Charlie McQuinn for lymphoma when they caught an unrelated lung cancer, he said.

Willis Knighton Cancer Center celebrate groundbreaking research on radiation therapy. According to Willis Knighton, physicist ...

Tagrisso was linked to higher cardiac risks in patients with EGFR-mutant NSCLC, including a four-fold rise in cardiac events ...

Lung cancer is a particularly challenging form of cancer. It often strikes unexpectedly and aggressively with little warning, ...

Ac-SSO110 has now received FDA orphan drug designation and investigational new drug application clearance for the treatment ...

SGMC Health has successfully performed its first robotic-assisted lung biopsy using the state-of-the-art Ion robot. The health system said the procedure marked a major advancement in lung cancer ...

A recent study found that structured cessation programs improve quit rates among lung cancer screening participants. How can physicians leverage this?

A quarter of a century ago, Britain shared the accolade of having the worst survival rates for cancer patients in Western ...

A new case report details a novel genetic mutation linked to drug resistance in a non-small cell lung cancer patient ...

Lung cancer is a source of more cancer deaths in the U.S. than breast, colon and prostate cancer combined. People diagnosed ...

MAIA Biotechnology, Inc. (NYSEAMERICAN: MAIA) disclosed information relating to its Phase 2 THIO-101 trial in advanced non-small cell lung cancer through a press release on February 4, 2025. According ...